[177Lu]Lu-OncoFAP-23
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [177Lu]Lu-OncoFAP-23, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors [Phase 1]